0001104659-23-085497.txt : 20230728
0001104659-23-085497.hdr.sgml : 20230728
20230728210147
ACCESSION NUMBER: 0001104659-23-085497
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230726
FILED AS OF DATE: 20230728
DATE AS OF CHANGE: 20230728
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Cramer Pamela J.
CENTRAL INDEX KEY: 0001873517
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38223
FILM NUMBER: 231124765
MAIL ADDRESS:
STREET 1: C/O RHYTHM PHARMACEUTICALS
STREET 2: 222 BERKELEY STREET, SUITE 1200
CITY: BOSTON
STATE: MA
ZIP: 02116
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: RHYTHM PHARMACEUTICALS, INC.
CENTRAL INDEX KEY: 0001649904
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 462159271
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 222 BERKELEY STREET
STREET 2: 12TH FLOOR
CITY: BOSTON
STATE: MA
ZIP: 02116
BUSINESS PHONE: 857-264-4280
MAIL ADDRESS:
STREET 1: 222 BERKELEY STREET
STREET 2: 12TH FLOOR
CITY: BOSTON
STATE: MA
ZIP: 02116
FORMER COMPANY:
FORMER CONFORMED NAME: RHYTHM METABOLIC, INC.
DATE OF NAME CHANGE: 20150803
4
1
tm2322368-1_4seq1.xml
OWNERSHIP DOCUMENT
X0508
4
2023-07-26
0
0001649904
RHYTHM PHARMACEUTICALS, INC.
RYTM
0001873517
Cramer Pamela J.
222 BERKELEY STREET, 12TH FLOOR
BOSTON
MA
02116
0
1
0
0
Chief Human Resources Officer
1
Common Stock
2023-07-26
4
M
0
3125
A
9348
D
Common Stock
2023-07-26
4
S
0
930
17.64
D
8418
D
Restricted Stock Units
2023-07-26
4
M
0
3125
0
D
Common Stock
3125
6250
D
Each restricted stock unit represents a contingent right to receive one share of Issuer common stock.
Includes 81 shares acquired under Issuer's Employee Stock Purchase Plan on February 28, 2023.
The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 instruction dated July 24, 2021 solely with the intent to cover withholding taxes in connection with the vesting of certain previously reported restricted stock units.
The restricted stock units vest or have vested as to 25% of the total shares on each of July 26, 2022, July 26, 2023, July 26, 2024 and July 26, 2025. The restricted stock units have no expiration date.
/s/ Hunter Smith, attorney-in-fact for Pamela J. Cramer
2023-07-28